UBB frame shifting mutation (UBB+1) impedes proteasomal proteolysis, and has been extensively identified in Alzheimer disease (AD), FTD and Huntington disease (HD) as pathological hallmark[67]. This evidence concerns the gene UBB and juvenile Huntington disease.